Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

SHE:002399 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	15,836	14,152	15,345	17,090	22,787	23,671
Market Cap Growth	15.36%	-7.78%	-10.21%	-25.00%	-3.74%	-2.72%
Enterprise Value	15,892	15,456	19,083	19,992	24,281	25,891
Last Close Price	11.84	10.47	11.49	12.47	16.56	16.52
PE Ratio	41.42	21.88	-	23.49	94.63	23.11
Forward PE	17.94	33.40	33.40	33.40	33.40	33.40
PS Ratio	2.94	2.69	2.83	2.39	3.58	4.44
PB Ratio	1.27	1.16	1.28	1.38	1.98	2.03
P/TBV Ratio	1.64	1.49	1.66	1.81	2.62	2.71
P/FCF Ratio	9.38	7.10	-	-	-	-
P/OCF Ratio	8.59	6.45	38.53	-	-	634.89
EV/Sales Ratio	2.95	2.94	3.51	2.79	3.82	4.86
EV/EBITDA Ratio	20.58	15.05	180.70	15.71	22.01	20.11
EV/EBIT Ratio	32.85	20.72	-	20.02	29.13	25.54
EV/FCF Ratio	9.41	7.75	-	-	-	-
Debt / Equity Ratio	0.25	0.29	0.46	0.52	0.49	0.48
Debt / EBITDA Ratio	3.37	3.33	38.64	4.95	4.98	4.28
Debt / FCF Ratio	1.83	1.78	-	-	-	-
Asset Turnover	0.31	0.29	0.27	0.36	0.33	0.31
Inventory Turnover	0.73	0.58	0.67	0.84	1.11	1.19
Quick Ratio	1.16	1.09	0.76	0.94	1.19	1.52
Current Ratio	2.39	2.60	2.13	2.22	2.25	2.53
Return on Equity (ROE)	3.23%	5.17%	-6.58%	5.97%	2.01%	10.66%
Return on Assets (ROA)	2.22%	2.55%	-0.68%	3.13%	2.73%	3.70%
Return on Invested Capital (ROIC)	4.21%	4.55%	-1.42%	6.00%	6.18%	5.98%
Return on Capital Employed (ROCE)	4.70%	5.50%	-1.50%	6.60%	5.80%	6.60%
Earnings Yield	2.65%	4.57%	-5.10%	4.26%	1.06%	4.33%
FCF Yield	10.67%	14.09%	-0.26%	-5.73%	-0.88%	-0.74%
Dividend Yield	2.02%	2.39%	-	0.80%	0.21%	0.91%
Payout Ratio	68.39%	-	-	34.51%	171.31%	43.69%
Buyback Yield / Dilution	0.56%	0.54%	-0.67%	-0.05%	-8.42%	-8.51%
Total Shareholder Return	2.58%	2.93%	-0.67%	0.75%	-8.21%	-7.60%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.